Remed Co (XKRX:302550) Interest Expense : ₩-1,198 Mil (TTM As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Remed Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Remed Co's interest expense for the three months ended in Mar. 2024 was ₩ -256 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-1,198 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Remed Co's Operating Income for the three months ended in Mar. 2024 was ₩ -185 Mil. Remed Co's Interest Expense for the three months ended in Mar. 2024 was ₩ -256 Mil. Remed Co did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Remed Co Interest Expense Historical Data

The historical data trend for Remed Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remed Co Interest Expense Chart

Remed Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-147.44

-416.03

-775.51

-966.80

-1,244.07

Remed Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-302.24	-341.68	-368.11	-232.05	-255.94

Remed Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,198 Mil.

Remed Co (XKRX:302550) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Remed Co's Interest Expense for the three months ended in Mar. 2024 was ₩-256 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₩-185 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ₩6,035 Mil.

Remed Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Remed Co did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Remed Co (XKRX:302550) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Remed Co Ltd (XKRX:302550) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

187 Techno 2-ro, No 301-303, Gwanpyeong-dong, Yuseong-gu, Daejeon, KOR, 34025

Website

http://www.remed.kr

Remed Co Ltd is a Korean medical equipment manufacturing company. The company is engaged in researching and developing products to treat brain disorders such as depression, anxiety, stroke and Parkin's. It has developed TMS device and is manufacturing pain therapy devices using advanced electromagnetic stimulation, shockwave (RSWT) and laser technologies. Its products offerings include Transcranial Magnetic simulator for brain, Electromagnetic simulators including Salus Talent, Salus Talent A, Salus Talent Pro, and Optimus Pro for pain therapy; and Rosetta, Salus RSWT and Optimus Pro as a part of Extracorporeal Shockwave Therapy. It also offers Electrosurgical units from REMED including ELPIS 4L, ELPIS 4, ELPIS 3, and ELPIS2.

Remed Co (XKRX:302550) Headlines

No Headlines